120 related articles for article (PubMed ID: 10963117)
1. Neuropeptides bombesin and calcitonin induce resistance to etoposide induced apoptosis in prostate cancer cell lines.
Salido M; Vilches J; López A
Histol Histopathol; 2000 Jul; 15(3):729-38. PubMed ID: 10963117
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptides bombesin and calcitonin inhibit apoptosis-related elemental changes in prostate carcinoma cell lines.
Salido M; Vilches J; López A; Roomans GM
Cancer; 2002 Jan; 94(2):368-77. PubMed ID: 11900223
[TBL] [Abstract][Full Text] [Related]
3. Etoposide sensitivity of human prostatic cancer cell lines PC-3, DU 145 and LNCaP.
Salido M; Larrán J; López A; Vilches J; Aparicio J
Histol Histopathol; 1999 Jan; 14(1):125-34. PubMed ID: 9987657
[TBL] [Abstract][Full Text] [Related]
4. [Effect of the neuropeptides bombesin and calcitonin on the growth of prostate cell lines, PC-3, DU 145, and LNCaP].
Larrán López J; Aparicio Patino J; López Muñoz A; Vilches Troya J
Actas Urol Esp; 2000; 24(10):779-84. PubMed ID: 11199293
[TBL] [Abstract][Full Text] [Related]
5. Changes in elemental concentrations in LNCaP cells are associated with a protective effect of neuropeptides on etoposide-induced apoptosis.
Salido M; Vilches J; Roomans GM
Cell Biol Int; 2004; 28(5):397-402. PubMed ID: 15193283
[TBL] [Abstract][Full Text] [Related]
6. Loss of mitochondrial membrane potential is inhibited by bombesin in etoposide-induced apoptosis in PC-3 prostate carcinoma cells.
Salido M; Gonzalez JL; Vilches J
Mol Cancer Ther; 2007 Apr; 6(4):1292-9. PubMed ID: 17431107
[TBL] [Abstract][Full Text] [Related]
7. Intracellular Elemental Patterns of Apoptosis Resistance in Transdifferentiated Androgen-Dependent Prostatic Carcinoma Cells.
Salido M; Vilches J
Microsc Microanal; 2016 Aug; 22(4):865-77. PubMed ID: 27487730
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin prevents apoptosis in prostate cancer cells.
Abasolo I; Montuenga LM; Calvo A
Regul Pept; 2006 Jan; 133(1-3):115-22. PubMed ID: 16297990
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status.
Serafin AM; Akudugu JM; Bohm L
Urol Res; 2002 Oct; 30(5):289-94. PubMed ID: 12389116
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptides, apoptosis and ion changes in prostate cancer. Methods of study and recent developments.
Vilches J; Salido M; Fernández-Segura E; Roomans GM
Histol Histopathol; 2004 Jul; 19(3):951-61. PubMed ID: 15168357
[TBL] [Abstract][Full Text] [Related]
11. Proliferation of prostate cancer cells and activity of neutral endopeptidase is regulated by bombesin and IL-1beta with IL-1beta acting as a modulator of cellular differentiation.
Albrecht M; Doroszewicz J; Gillen S; Gomes I; Wilhelm B; Stief T; Aumüller G
Prostate; 2004 Jan; 58(1):82-94. PubMed ID: 14673956
[TBL] [Abstract][Full Text] [Related]
12. Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells.
Berchem GJ; Bosseler M; Sugars LY; Voeller HJ; Zeitlin S; Gelmann EP
Cancer Res; 1995 Feb; 55(4):735-8. PubMed ID: 7850782
[TBL] [Abstract][Full Text] [Related]
13. Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines.
Jongsma J; Oomen MH; Noordzij MA; Romijn JC; van Der Kwast TH; Schröder FH; van Steenbrugge GJ
Prostate; 2000 Jan; 42(1):34-44. PubMed ID: 10579797
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterization of bombesin and calcitonin on the proliferation of PC3, DU 145 and LNCaP cancer prostatic cell lines.
Larrán J; Salido M; Aparicio J; López A; de Palacio ML; Vilches J
Int J Dev Biol; 1996; Suppl 1():275S-276S. PubMed ID: 9087795
[No Abstract] [Full Text] [Related]
15. Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase.
Sumitomo M; Asano T; Asakuma J; Asano T; Nanus DM; Hayakawa M
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):260-6. PubMed ID: 14734478
[TBL] [Abstract][Full Text] [Related]
16. X-ray microanalysis of etoposide-induced apoptosis in the PC-3 prostatic cancer cell line.
Salido M; Vilches J; Lopez A; Roomans GM
Cell Biol Int; 2001; 25(6):499-508. PubMed ID: 11407855
[TBL] [Abstract][Full Text] [Related]
17. Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment.
Uemura H; Chang C
Endocrinology; 1998 May; 139(5):2329-34. PubMed ID: 9564841
[TBL] [Abstract][Full Text] [Related]
18. Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.
Mimeault M; Venkatraman G; Johansson SL; Moore E; Henichart JP; Depreux P; Lin MF; Batra SK
Int J Cancer; 2007 Jan; 120(1):160-9. PubMed ID: 17013895
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
Lee LF; Guan J; Qiu Y; Kung HJ
Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275
[TBL] [Abstract][Full Text] [Related]
20. Etoposide induces growth arrest and disrupts androgen receptor signaling in prostate cancer cells.
Liu S; Yamauchi H
Oncol Rep; 2010 Jan; 23(1):165-70. PubMed ID: 19956877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
